Yuwei Xu

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 3

Top Topics

Prostate Cancer

Inflammatory Response

Top Venues

Drug design, development and therapy

Bioscience reports

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Mei, Jing Ma, Yuwei Xu, Yuanyuan Wang, Minghua Hu, Fangli Ma, Zhihai Qin, Rui Xue, Ning Tao
Cinnamaldehyde Treatment of Prostate Cancer-Associated Fibroblasts Prevents Their Inhibitory Effect on T Cells Through Toll-Like Receptor 4. Drug design, development and therapy 14 (2020)
Yuwei Xu, Jing Ma, Qilin Zheng, Yuanyuan Wang, Minghua Hu, Fangli Ma, Zhihai Qin, Ningjing Lei, Ning Tao
MPSSS impairs the immunosuppressive function of cancer-associated fibroblasts via the TLR4-NF-κB pathway. Bioscience reports 39 (5) (2019)
Ying Ding, Zecheng Yang, Wensheng Zhang, Yuwei Xu, Yuanyuan Wang, Minghua Hu, Fangli Ma, Hanan Long, Ning Tao, Zhihai Qin
Eugenol triggers CD11b + Gr1 + myeloid-derived suppressor cell apoptosis via endogenous apoptosis pathway. RSC advances 8 (7) (2018)